@RoyHDecker, the impact you have made on your family, friends, colleagues, trainees, patients, and the lung cancer community has been enormous. We will miss your kindness, wisdom, humor, and clear-headedness so much. We will all do our best to honor your legacy. Rest in peace.
James Laird speaking about Predictors of Early Polymetastasis after Comprehensive Local Therapy for Synchronous Oligometastatic NSCLC during this morning’s #ASTRO22 session on Novel Prospective Radiation/Immunotherapy Combinations and Oligometastasis
@HenryParkMD@YaleCancer
Our very own Dr. Roy Decker was awarded the 2022 Mark Reitsma Courage Award at this year's #CTFRide in recognition of riders battling cancer. As a former program director, he is a pillar of our residency and an inspiration to us all.
‼️ATTN Med Students‼️
Come join us 9/13/22 @ 5PM EST for our annual Meet & Greet where you can meet our team and learn about our program.
Register below⬇️
https://t.co/XeIJjiYSSP
The @AmerMedicalAssn is the most powerful voice advocating on behalf of all physicians, spending an average of $18 million annually on lobbying efforts, and @ASTRO_org needs to retain their seat.
#Radonc friends, consider joining the AMA today!
https://t.co/2qKnILpu6x
Alright chums, let's do this - LEEEROO...wait.
I mean to say: if you're interested in a podcast aimed at emulating the spontaneous conversations we have during a clinic day with "practical learning", then join us in the sunlight, Out of the Basement.
For patients, each moment spent dealing with new bureaucracy and further treatment delays is not only emotionally excruciating, but also potentially life-threatening.
https://t.co/vutr6Bxv3D
Alright, soft launch, everyone pretend you didn't see this but - we're doing a whole media network thing, here's the opening episodes on contracts...
https://t.co/EN4KYtJwiO
Happy that the House passed the Advancing #Telehealth Beyond #COVID19 Act (#HR4040) extension through 2024. We should make this permanent!
#Telemedicine is not perfect but 2⃣ out of 3⃣ patients reported reduced treatment-related costs ⬇️#financialToxicity
https://t.co/XREu1AvJgV
Chief resident @SusanGueble and MD PhD student @LinKingson, in collaboration with the @ranjitbindra and @HerzonLab labs discovered a new class of tumor-selective DNA cross-linking agents that target drug-resistant glioma @ScienceMagazine
https://t.co/uDG3kICoX2